NCT00266721

Efficacy of Pancrelipase on Postprandial Belching and Bloating.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 45 (planned)
• Sponsor: Solvay Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The hypothesis of this study is that the administration of pancrelipase with meals will benefit symptoms of post-prandial bloating, pain and eructation.

Detailed description

Subjects will complete a double-blind crossover study in which, for one week periods, they will receive two pancrelipase tablets with each of the three major meals or a similarly administered identical placebo. Three times daily, subjects will rate the severity of belching, epigastric discomfort, epigastric fullness, bloating, and nausea.

Conditions

• Postprandial Bloating
• Postprandial Belching
• Postprandial Eructation

Interventions

Type	Name	Description
DRUG	Pancrelipase (Creon) 2 tablets with each meal

Timeline

• Start date: 2000-01-01
• Completion: 2000-10-01
• First posted: 2005-12-19
• Last updated: 2005-12-19

Locations

1 site across 1 country: United States